Progress toward improved Wilson’s disease drug

(Cold Spring Harbor Laboratory) Researchers at CSHL, working in collaboration with DepYmed Inc., a CSHL spinout company, today report that they have conducted promising preclinical experiments on a compound that could be used to treat Wilson's disease and possibly other disorders — including certain types of cancer — in which levels of copper in the body are elevated, causing or contributing to pathology.

Comments
%d bloggers like this: